A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose*

https://doi.org/10.1016/S0001-2998(89)80034-0Get rights and content

A practical quantitative single photon emission computed tomographic (SPECT) technique based on an empirical threshold analysis permits accurate measurements in humans of drug delivery and absorbed radiation dose. The limits of the method have been explored using a wide range of phantom volumes, concentrations, and target-to-nontarget ratios. A threshold of 43% was found to give the best results using volumes of 30 to 3,800 cc. An excellent correlation (r=99 with a standard error of estimate [SEE] of 41 cc) was found between SPECT measured volumes and actual phantom volumes. A similarly high correlation (r=.98, SEE=260 counts/voxel) was found in 77 measurements of concentrations between 0.01 and 3.6 μCi/cc. There was a direct relationship between the target-to-nontarget ratio of phantoms and the accuracy of volume measurements. The technique has been validated by an excellent in vivo/in vitro correlation of uptake in human tumors. The tumor cumulative concentration and tumor-to-blood ratio were used for assessment of drug delivery. In vivo quantitative measurements of the pharmacokinetics of technetium-99m (99mTc) glucoheptonate, cobalt-57 (57Co) bleomycin and platinum-195m (195mPt) cisplatin in human tumors in vivo indicates that, in contrast with tumor models in animals, there is a marked variability in drug delivery even in tumors with the same histology. Future development of labeled drugs should make it possible to use quantitative SPECT for predicting tumor response to therapy and for tailoring chemotherapy for the individual patient under treatment. SPECT quantitation of organ concentration was used for Medical Internal Radiation Dose committee (MIRD) calculations of organ absorbed radiation dose from 99mTc-labeled RBCs. Excellent in vivo/in vitro correlations were obtained between SPECT measured concentrations of blood radioactivity in the heart and in vitro measurements of blood samples. The possibilities and limitations of this technique are discussed and its use for in vivo measurement in humans of absorbed radiation dose from radiopharmaceuticals is suggested.

References (48)

  • FreiE et al.

    Dose: A critical factor in cancer chemotherapy

    Am J Med

    (1980)
  • DeNardoGL et al.

    Requirements for a treatment planning system for radioimmunotherapy

    Int J Radiat Oncol Biol Phys

    (1985)
  • RiordanJR et al.

    Genetic and biochemical characterization and multidrug resistance

    Pharmacol Ther

    (1985)
  • FrontD et al.

    In vivo quantitation using SPECT of radiopharmaceutical uptake by human meningiomas

    Radiology

    (1987)
  • FrontD et al.

    Human lung tumors: SPECT quantitation of differences in Co-57 bleomycin uptake

    Radiology

    (1987)
  • FrontD et al.

    SPECT quantitation of Co-57 bleomycin delivery to human brain tumors

    J Nucl Med

    (1988)
  • BenetLZ et al.

    Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination,

  • DeVitaVT

    Dose-response is alive and well

    J Clin Oncol

    (1986)
  • HryniukW et al.

    Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

    J Clin Oncol

    (1986)
  • MurphyPH

    Quantitative emission tomography

    J Nucl Med

    (1987)
  • TauxeWN et al.

    Determination of organ volume by single photon emission computed tomography

    J Nucl Med

    (1982)
  • SoderborgD et al.

    Letter to the editor

    J Nucl Med

    (1983)
  • MortelmansL et al.

    A new threshold method for volume determination by SPECT

    Eur J Nucl Med

    (1986)
  • KircosLT et al.

    Quantitative organ visualization using SPECT

    J Nucl Med

    (1987)
  • BaileyDL et al.

    Improved SPECT using simultaneous emission and transmission tomography

    J Nucl Med

    (1987)
  • MaceyDJ et al.

    Comparison of three boundary detection methods for SPECT using compton scattered photons

    J Nucl Med

    (1988)
  • KoralKF et al.

    SPECT compton-scattering correction by analysis of energy spectra

    J Nucl Med

    (1988)
  • BrooksRA et al.

    Scientists advocate using empirical data from physiologic PET and SPECT images

    J Nucl Med

    (1986)
  • NonelJP et al.

    Le bleomycine marquee au Do-57. Interet dans le diagnostique des tumeurs malignes et de leur extension

    Nouv Presse Med

    (1972)
  • SuzukiY et al.

    Clinical evaluation of tumor scanning with Co-57 bleomycin

    Radiology

    (1974)
  • RaskerJJ et al.

    Some experience with Co-57 as a tumor seeking agent

    J Nucl Med

    (1975)
  • GroveRB et al.

    Clinical evaluation of radiolabeled bleomycin (bleo) for tumor detection

    J Nucl Med

    (1974)
  • CochaviS et al.

    Dose evaluation of Co-55 bleomycin

    Med Phys

    (1979)
  • BeekhuisH et al.

    Radiation absorbed doses from Co-57 and Co-55 bleomycin

    J Nucl Med

    (1984)
  • Cited by (0)

    *

    Supported by grants from the J.Tal Equipment and Research Fund of the Technion, Israel Cancer Association and the Biomedical Research Support Funds of Beth Israel Hospital. 57Co was generously donated by DuPont Imaging Division, Billerica, MA.

    View full text